Novavax, Inc.(NVAX)- NASDAQ
  • Jun. 4, 2013, 7:52 AM

    Novavax (NVAX) makes a public offer to acquire all outstanding shares of Isconova, a Sweden-based company which makes vaccine adjuvants and has an impressive list of big pharma partners. The all-stock deal is worth~$29.6M. (PR)

    | Jun. 4, 2013, 7:52 AM